These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 2760841)
1. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. Flynn DD; Mash DC J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841 [TBL] [Abstract][Full Text] [Related]
2. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors. Potter LT; Ferrendelli CA; Hanchett HE; Hollifield MA; Lorenzi MV Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474 [TBL] [Abstract][Full Text] [Related]
3. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
5. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB; Creese I Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes. Sallés J; Wallace MA; Fain JN J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum. James MK; Cubeddu LX J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384 [TBL] [Abstract][Full Text] [Related]
8. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581 [TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M; Waelbroeck M; Christophe J Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [TBL] [Abstract][Full Text] [Related]
10. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert. Gil DW; Wolfe BB J Pharmacol Exp Ther; 1986 May; 237(2):577-82. PubMed ID: 3009794 [TBL] [Abstract][Full Text] [Related]
11. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration. Lee W; Wolfe BB Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673 [TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265 [TBL] [Abstract][Full Text] [Related]
13. Effect of tacrine on in vivo release of dopamine and its metabolites in the striatum of freely moving rats. Warpman U; Zhang X; Nordberg A J Pharmacol Exp Ther; 1996 May; 277(2):917-22. PubMed ID: 8627574 [TBL] [Abstract][Full Text] [Related]
14. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart. Wang JX; Mei L; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203 [TBL] [Abstract][Full Text] [Related]
15. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain. Norman AB; Eubanks JH; Creese I J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964 [TBL] [Abstract][Full Text] [Related]
16. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors. Nilvebrant L Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114 [TBL] [Abstract][Full Text] [Related]
17. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW; Binder HJ Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [TBL] [Abstract][Full Text] [Related]
19. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex. Forray C; el-Fakahany EE Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates. Lee JH; el-Fakahany EE J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]